BioSpace News Archive

Drug Development

LIXTE Biotechnology Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations

LIXTE Biotechnology Holdings, Inc announces that Professor René Bernards, Netherlands Cancer Institute (NKI), Amsterdam, presented new data from promising drug combinations of LIXTE’s lead clinical cancer compound, LB-100, at the Annual Meeting of American Association for Cancer Research.

April 12, 2022
·
4 min read
Business

SERA PROGNOSTICS ANNOUNCES THE APPOINTMENT OF DR. JANE F. BARLOW TO THE SERA PROGNOSTICS BOARD

Sera Prognostics Inc. today announced that Dr. Jane F. Barlow has joined the Sera Board of Directors.

April 12, 2022
·
6 min read
Deals

Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Kintara Therapeutics, Inc. today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of 16,226,416 shares of the Company’s common stock.

April 12, 2022
·
5 min read
Business

Bearpac Medical Announces Exclusive UK Distribution Agreement with APR Medtech Ltd for the Passio™ Pump Drainage System

Bearpac Medical, LLC is pleased to announce that it has entered into an exclusive distribution agreement with APR Medtech Ltd (Thame, Oxon, UK) to sell the Passio Pump Drainage System, indicated for the intermittent drainage of recurrent and symptomatic pleural effusions and malignant ascites.

April 12, 2022
·
1 min read